ZZ Biotech

Houston, United States Founded: 2006 • Age: 20 yrs
Genetically engineered proteins for stroke and brain disorders are developed.
Request Access

About ZZ Biotech

ZZ Biotech is a company based in Houston (United States) founded in 2006.. ZZ Biotech has completed 1 acquisition, including Bioatrix. ZZ Biotech offers products and services including 3K3A-APC. ZZ Biotech operates in a competitive market with competitors including Basking Biosciences, Acticor Biotech, Remedy Pharmaceuticals, Alveron Pharma and Aurum Biosciences, among others.

  • Headquarter Houston, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Zz Biotech, Llc
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Investments & Acquisitions
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of ZZ Biotech

ZZ Biotech offers a comprehensive portfolio of products and services, including 3K3A-APC. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Genetically engineered variant of human protein C for therapeutic applications.

People of ZZ Biotech
Headcount 1-10
Employee Profiles 4
Board Members and Advisors 3
Employee Profiles
People
Kent E. Pryor
CEO & Director
People
Susan Willingham
Director, Finance
People
Craig Van De Mark
Director & VP, Legal
People
Lisa Koch-Hulle
Head, Regulatory Affairs

Unlock access to complete

Board Members and Advisors
people
Joseph J. Romano
Executive Chairman
people
Tadeusz Wellisz
Director
people
Jay Hennock
Director

Unlock access to complete

Funding Insights of ZZ Biotech

  • Total Funding
  • Total Rounds 1
  • Last Round
  • First Round
  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2014 Amount Grant - ZZ Biotech Valuation

investors

NIH
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in ZZ Biotech

ZZ Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include NIH. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Drug discovery services are provided to the biopharma sector.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by ZZ Biotech

ZZ Biotech has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Bioatrix. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Developing activated protein C (aPC)-based products primarily for wound healing
2012
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - ZZ Biotech

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Zz Biotech Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of ZZ Biotech

ZZ Biotech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Basking Biosciences, Acticor Biotech, Remedy Pharmaceuticals, Alveron Pharma and Aurum Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutics for ischemic stroke treatment are developed.
domain founded_year HQ Location
Immunotherapeutics are developed for ischemic stroke treatment using monoclonal antibodies.
domain founded_year HQ Location
Intravenous formulation for acute central nervous system conditions such as stroke (ischemic and hemorrhagic), traumatic brain injury.
domain founded_year HQ Location
Drugs for haemorrhagic stroke and intracranial haemorrhage are developed.
domain founded_year HQ Location
Novel oxygen carriers and MRI software for stroke are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Zz Biotech

Frequently Asked Questions about ZZ Biotech

When was ZZ Biotech founded?

ZZ Biotech was founded in 2006 and raised its 1st funding round 8 years after it was founded.

Where is ZZ Biotech located?

ZZ Biotech is headquartered in Houston, United States. It is registered at Houston, Texas, United States.

Who is the current CEO of ZZ Biotech?

Kent Pryor is the current CEO of ZZ Biotech.

What does ZZ Biotech do?

ZZ Biotech was founded in 2006 in Houston, United States, within the biotechnology sector. Focus is placed on biological therapies for conditions affecting the aging and damaged brain, such as stroke and neurodegenerative diseases. The lead product, 3K3A-APC, represents a modified form of activated protein C and is undergoing phase 2 clinical trials. Functions related to cell protection, inflammation reduction, and blood clotting regulation are attributed to this candidate.

Who are the top competitors of ZZ Biotech?

ZZ Biotech's top competitors include Acticor Biotech, Remedy Pharmaceuticals and Basking Biosciences.

What products or services does ZZ Biotech offer?

ZZ Biotech offers 3K3A-APC.

How many acquisitions has ZZ Biotech made?

ZZ Biotech has made 1 acquisition, including Bioatrix.

Who are ZZ Biotech's investors?

ZZ Biotech has 1 investor. Key investors include NIH.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available